Skip to main content
Stem Cell Research & Therapy logoLink to Stem Cell Research & Therapy
. 2024 Apr 22;15:110. doi: 10.1186/s13287-024-03733-0

Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

Alexander Markov 1, Lakshmi Thangavelu 2, Surendar Aravindhan 3, Angelina Olegovna Zekiy 4, Mostafa Jarahian 5, Max Stanley Chartrand 6, Yashwant Pathak 7, Faroogh Marofi 8, Somayeh Shamlou 9, Ali Hassanzadeh 9,10,11,
PMCID: PMC11034067  PMID: 38644488

Retraction Note: Stem Cell Research & Therapy (2021) 12:192

10.1186/s13287-021-02265-1

The Editors-in-Chief have retracted this article. An investigation by the Publisher has found a number of articles, including this one, which share similar concerns, involving but not limited to, irregularities with respect to submission and authorship. The Editors-in-Chief therefore no longer have confidence in the results and conclusions presented in this article. Alexander Markov, Lakshmi Thangavelu, and Ali Hassanzadeh do not agree to this retraction. Surendar Aravindhan, Angelina Olegovna Zekiy, Mostafa Jarahian, Max Stanley Chartrand, Yashwant Pathak, Faroogh Marofi and Somayeh Shamlou did not respond to correspondence from the Editor about this retraction.

Footnotes

The online version of the original article can be found at 10.1186/s13287-021-02265-1.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Articles from Stem Cell Research & Therapy are provided here courtesy of BMC

RESOURCES